Novel quinoxalinone derivatives as bradykinin b1 antagonists

Details Novel quinoxalinone derivatives as bradykinin b1 antagonists Novel quinoxalinone derivatives as bradykinin b1 antagonists

C - Chemistry, Metallurgy

07

D

C07D 471/04 (2006.01) A61K 31/498 (2006.01) A61K 31/5377 (2006.01) A61P 19/02 (2006.01) A61P 29/00 (2006.01) C07D 241/44 (2006.01) C07D 241/50 (2006.01) C07D 401/12 (2006.01) C07D 403/10 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 409/14 (2006.01) C07D 413/12 (2006.01)

Patent

CA 2507425

2-Quinoxalinone derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.

L'invention concerne des dérivés de 2-Quinoxalinone constituant des antagonistes ou agonistes inverses B1 de la bradykinine, utilisés dans le traitement ou la prévention des symptômes tels que la douleur et l'inflammation associées à la voie B1 de la bradykinine.

Affiliated with

Also associated with

Rating

Novel quinoxalinone derivatives as bradykinin b1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel quinoxalinone derivatives as bradykinin b1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel quinoxalinone derivatives as bradykinin b1 antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1706514